Nykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in HPV16-Positive Cervical Cancer
September 05, 2023 01:00 ET
|
Nykode Therapeutics ASA
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20. OSLO, Norway, Sept. 05,...
Nykode Therapeutics - Quarterly report Q2 2023
August 23, 2023 00:45 ET
|
Nykode Therapeutics ASA
OSLO, Norway, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...